AstraZeneca receives CDSCO approval for Enhertu followed by THP for adults with HER2-positive stage II...

AbbVie announces availability of ELAHERE in Singapore for the treatment of platinum-resistant Ovarian cancer

ImmunityBio receives UAE Marketing Authorization for ANKTIVA in BCG-unresponsive NMIBC (CIS and papillary disease) and...

DualityBio and BioNTech’s B7-H3 ADC DB-1311 granted China NMPA BTD for metastatic castration-resistant Prostate cancer

Gilead announces CHMP recommendation for Trodelvy + Keytruda in 1L PD-(L)1+ mTNBC

EU CHMP recommends Enhertu plus Pertuzumab for 1L HER2 metastatic Breast cancer